Search

Your search keyword '"Searleman, Adam C."' showing total 134 results

Search Constraints

Start Over You searched for: Author "Searleman, Adam C." Remove constraint Author: "Searleman, Adam C."
134 results on '"Searleman, Adam C."'

Search Results

2. Inversion recovery UTE based volumetric myelin imaging in human brain using interleaved hybrid encoding

3. Assessment of an in vitro model of rotator cuff degeneration using quantitative magnetic resonance and ultrasound imaging with biochemical and histological correlation

4. Fast quantitative 3D ultrashort echo time MRI of cortical bone using extended cones sampling

5. True phase quantitative susceptibility mapping using continuous single‐point imaging: a feasibility study

6. Collagen proton fraction from ultrashort echo time magnetization transfer (UTE‐MT) MRI modelling correlates significantly with cortical bone porosity measured with micro‐computed tomography (μCT)

11. Supplementary Figure 4 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

13. Supplementary Table 1 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

14. Supplementary Figure 5 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

16. Supplementary Figure 3 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

17. Supplementary Figure 7 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

18. Supplementary Figures S1 - S8 from HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment

19. Supplementary Figure 6 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

20. Supplementary Figure 2 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

21. Supplementary Figure 1 from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

22. Supplementary Figure Legend from Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

23. Data from A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth

24. Supplementary Methods, Figures 1-7, Tables 1-3 from A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth

25. Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription

32. Anesthesia awareness and the bispectral index

33. Evaluation of enzymatic proteoglycan loss and collagen degradation in human articular cartilage using ultrashort echo time‐based biomarkers: A feasibility study.

38. Assessment of an in vitro model of rotator cuff degeneration using quantitative magnetic resonance and ultrasound imaging with biochemical and histological correlation

39. Cortical bone porosity measured with micro computed tomography (μCT) correlates significantly with collagen protons fraction from ultrashort echo time magnetization transfer (UTE-MT) MRI modeling

43. Long-term Cognitive Decline in Older Subjects Was Not Attributable to Noncardiac Surgery or Major Illness

45. HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment

47. Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

48. A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth

50. Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription.

Catalog

Books, media, physical & digital resources